• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Everyone is leaving Salvin





Are things as bad as Pattersn as they seem? Huge turn over four branch managers recently left for Schein, at least a dozen open cerec specialist positions open according to the corp website and over 50 territory rep positions open. I'm wondering if it's the fact that Patterson doesn't pay employees for expenses, the low base or the lack of career opportunity within the company that is behind this desertion.